Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.65 | 1.44 |
NAV | ₹520.83 | ₹108.10 |
Fund Started | 12 Aug 2002 | 08 Apr 2008 |
Fund Size | ₹29323.25 Cr | ₹63938.03 Cr |
Exit Load | Exit load of 1% if redeemed within 90 days. | Exit load of 1% if redeemed upto 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 23.96% | 25.71% |
3 Year | 14.97% | 18.13% |
5 Year | 17.94% | 19.96% |
1 Year
3 Year
5 Year
Equity | 98.19% | 92.69% |
Cash | 1.44% | 6.96% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.77% |
ICICI Bank Ltd. | 7.70% |
Infosys Ltd. | 6.36% |
Larsen & Toubro Ltd. | 4.95% |
Reliance Industries Ltd. | 4.75% |
Bharti Airtel Ltd. | 3.53% |
Mahindra & Mahindra Ltd. | 3.14% |
Axis Bank Ltd. | 3.00% |
ITC Ltd. | 2.68% |
NTPC Ltd. | 2.66% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.14% |
ICICI Bank Ltd. | 8.24% |
Larsen & Toubro Ltd. | 6.64% |
Infosys Ltd. | 4.87% |
Reliance Industries Ltd. | 4.41% |
Bharti Airtel Ltd. | 4.37% |
Axis Bank Ltd. | 4.17% |
Maruti Suzuki India Ltd. | 4.11% |
Ultratech Cement Ltd. | 4.01% |
Sun Pharmaceutical Industries Ltd. | 2.80% |
Name | Dhaval Joshi | Vaibhav Dusad |
Start Date | 21 Nov 2022 | 02 May 2020 |
Name
Start Date
Description | The scheme seeks long term growth of capital, through a portfolio with a target allocation of 100% equity by aiming at being as diversified across various industries and/ or sectors as its chosen benchmark index, Nifty 50. The secondary objective | The scheme seeks to generate long term capital appreciation and income distribution to investors from a portfolio that is predominantly invested in equity and equity related securities of large cap companies. |
Launch Date | 12 Aug 2002 | 08 Apr 2008 |
Description
Launch Date